<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ALIM</title>
    <link />
    <description>Headlines for Alimera Sciences, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>A Peek Into The Market Before The Trading Starts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3676462/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 14 Jun 2013 07:21:43 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences Announces Positive UK Appraisal Recommendation On ILUVIEN</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3676362/alimera-sciences-announces-positive-uk-appraisal-recommendation-on-iluvien.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 14 Jun 2013 06:38:30 GMT</pubDate>
    </item>
    <item>
      <title>What Iluvien May Mean To Alimera And PSivida</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1482571-what-iluvien-may-mean-to-alimera-and-psivida.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 05 Jun 2013 12:30:29 GMT</pubDate>
    </item>
    <item>
      <title>SmithOnStocks Opines Week Of June 2, 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1476151-smithonstocks-opines-week-of-june-2-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 03 Jun 2013 07:00:12 GMT</pubDate>
    </item>
    <item>
      <title>Ophthalmology Innovators: Will InSite Follow Recent Successes?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1441401-ophthalmology-innovators-will-insite-follow-recent-successes.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 15:59:43 GMT</pubDate>
    </item>
    <item>
      <title>For Iluvien, The FDA Isn't The Issue; European Sales Are</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1364741-for-iluvien-the-fda-isn-t-the-issue-european-sales-are.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 24 Apr 2013 03:04:46 GMT</pubDate>
    </item>
    <item>
      <title>Is The Third Time The Charm For ILUVIEN?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1321411-is-the-third-time-the-charm-for-iluvien.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 04 Apr 2013 14:28:43 GMT</pubDate>
    </item>
    <item>
      <title>Ampio's Eye Drug Trial Design Won't Pass FDA Muster</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11884765/1/ampios-eye-drug-trial-design-wont-pass-fda-muster.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 02 Apr 2013 09:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1294121-alimera-sciences-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 18:30:07 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for March 21, 2013 :  NKE, SLW, MU, TIBX, RUE, NWY, ALIM</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-march-21-2013-nke-slw-mu-tibx-rue-nwy-alim-cm229492.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 21 Mar 2013 14:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences: About To Cash In?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1287071-alimera-sciences-about-to-cash-in.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Mar 2013 15:54:24 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences: A Sleeping Giant</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1174771-alimera-sciences-a-sleeping-giant.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Feb 2013 11:47:45 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Receives Marketing Authorization In Spain for ILUVIEN</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3251517/alimera-receives-marketing-authorization-in-spain-for-iluvien.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 17 Jan 2013 07:32:36 GMT</pubDate>
    </item>
    <item>
      <title>Biotechnology In 2012: The Best Performing Industry</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1043311-biotechnology-in-2012-the-best-performing-industry.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Dec 2012 08:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences Management Discusses Q3 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/988521-alimera-sciences-management-discusses-q3-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 07 Nov 2012 18:00:05 GMT</pubDate>
    </item>
    <item>
      <title>Alimera Sciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/800851-alimera-sciences-ceo-discusses-q2-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 11 Aug 2012 23:51:02 GMT</pubDate>
    </item>
    <item>
      <title>10 Healthcare Stocks With Scheduled July Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/695561-10-healthcare-stocks-with-scheduled-july-catalysts.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 02 Jul 2012 03:56:01 GMT</pubDate>
    </item>
    <item>
      <title>Buy, Sell, or Hold: MannKind</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/06/29/buy-sell-or-hold-mannkind/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 29 Jun 2012 14:39:57 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Avoiding the Doom and Gloom of Europe</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/06/27/stocks-avoiding-the-doom-and-gloom-of-europe/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 27 Jun 2012 20:04:25 GMT</pubDate>
    </item>
    <item>
      <title>Bio Pharma Momentum Movers For Today: Will Arena's Weight Loss Drug Lorcaserin Be Approved?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/686231-bio-pharma-momentum-movers-for-today-will-arena-s-weight-loss-drug-lorcaserin-be-approved.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Jun 2012 07:35:00 GMT</pubDate>
    </item>
  </channel>
</rss>
